Skip to main content
. 2017 Dec 19;9(3):4034–4043. doi: 10.18632/oncotarget.23428

Figure 2.

Figure 2

Local progression-free survival (LPFS) (A), relapse-free survival (RFS) (B), and overall survival (OS) (C) curves in all patients.